PUT - SPRINTER OPEN END - BIOGEN IDEC | Market Closed - Boerse Frankfurt Warrants 13:45:00 2024-04-30 EDT | ||
| 20.61 EUR | +0.78% |
|
| Current month | +0.98% | ||
| 1 month | +0.98% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 20.61 | +0.78% | 0 |
| 24-04-29 | 20.45 | -3.49% | 0 |
| 24-04-26 | 21.19 | -2.98% | 0 |
| 24-04-25 | 21.84 | -0.95% | 0 |
| 24-04-24 | 22.05 | -2.43% | 0 |
Real-time Boerse Frankfurt Warrants
Last update April 30, 2024 at 01:45 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VQ8H8V |
| ISIN | DE000VQ8H8V0 |
| Date issued | 2021-06-09 |
| Strike | 433.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.33 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 24.13 € |
|---|---|
| Lowest since issue | 1.78 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
215.5
USD
Average target price
286
USD
Spread / Average Target
+32.70%
- Stock Market
- Certificates
- Certificat
